Aeglea BioTherapeutics, Inc.

-

Assets, Funds, Holdings

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Aeglea BioTherapeutics, Inc.
CIK #0001636282
EDGAR Form CIK 2011 - 2024
10-K [0001636282]
10-Q [0001636282]
3 [0001636282]
4 [0001636282]
5 [0001636282]
8-K [0001636282]
D [0001636282]
SC 13D [0001636282]
SC 13G [0001636282]
Form 13D/13G Filer Form 13D/13G Subject Filed
RTW Investments LP Spyre Therapeutics Inc [2024-02-14]
Avoro Capital Advisors LLC Spyre Therapeutics Inc [2024-02-14]
FMR LLC Spyre Therapeutics Inc [2024-02-09]
Perceptive Advisors LLC Spyre Therapeutics Inc [2023-12-13]
Commodore Capital LP Spyre Therapeutics Inc [2023-12-01]
Deutsch Peter E Aeglea Biotherapeutics Inc [2023-11-14]
Polar Capital Holdings PLC Aeglea Biotherapeutics Inc [2023-07-28]
Logos Global Management LP Aeglea Biotherapeutics Inc [2023-07-18]
Venrock Healthcare Capital Partners III LP Aeglea Biotherapeutics Inc [2023-07-10]
Affinity Asset Advisors LLC Aeglea Biotherapeutics Inc [2023-07-03]
View All
Form 3/4/5 Subject 2011 - 2024
Sloan Sheldon
Spyre Therapeutics, Inc.
Burrows Scott L
Milligan Sandra
Stelzer Laurie
Albers Jeffrey W.
Henderson Michael Thomas
Harwin Peter Evan
Fairmount Funds Management LLC
Kiselak Tomas
View All
Terms | Privacy | Guide
tony@aum13f.com